Gambaran Interaksi Obat Pada Pasien Gagal Ginjal Kronik Dalam Proses Hemodialisis
Abstract
Chronic Kidney Disease (CKD) is a condition in which there is a decrease in kidney function due to the presence of chronic and irreversible renal parenchyma. Patients with chronic disease often require a combination of several drugs. The administration of drugs combination is generally expected to have a beneficial effect. However, in some cases, drug interactions resulted in ineffective treatment and the emergence of unexpected events. This research aimed to determine drug interactions in patients with chronic kidney disease who are undergoing hemodialysis in the Inpatient Installation of Dr. M.M Dunda Limboto Hospital. This research was observational using a cross-sectional design and retrospective data collection. The sampling technique used was a purposive sampling technique with a total of 51 patient who met the inclusion criteria during the July-Desember 2020 period. Drug interaction data analysis was based on the Drug Interaction Checker and Drug Interaction Facts. The results showed that the most widely used drugs in patients with chronic kidney disease at Dr. M.M Dunda Limboto Hospital were anti-hypertensi drugs (17%), vitamins and minerals (13.30%), and gastrointestinal (11.32%). Drugs interactions with pharmacodynamic mechanisms were 31 cases (53.45%), pharmacokinetics were 21 cases (36.21%), and 6 cases were unknown (10.34%). The level of clinical significance in patients with chronic kidney disease was 75.86% moderate, 13.80% minor, and 10.34% major.
Keywords
Full Text:
PDFReferences
World Health Organization. 2018. Deafness And Hearing Loss. [Cited 2018 Januari 4], Available From : Http://Www.Who.Int/Mediacentre/Factsheets/Fs300/En/
World Health Organization. 2013. A Global Brief On Hypertension: Silent Killer. Global Public Health Crisis. Http://Apps.Who.Int/Iris/Bitstream/10665/79059/1/Who_Dco_Whd_2013.2_Eng.Pdf?Ua=1 – DiaksesOktober 2017.
Fransisca, Kristiana. 2011. Waspadalah 24 Penyebab Ginjal Rusak. Jakarta: Penerbit Cerdas Sehat.
Riskesdas, 2018.Riset Kesehatan Dasar, Jakarta: Badan Penelitian Dan Pengembangan Kesehatan Ri.
O’callaghan, Chris, A. 2009. At A Glance sistem Ginjal.Edisi Kedua. Jakarta: Erlangga.
National Kidney Foundation [Internet]. 2016. About Chronic Kidney Disease; 2016 [Dikutip 29 Jan 2017]; [1 Halaman]. Diambil Dari: Https://Www.Kidney.Org/Kidneydisease/Aboutckd. New York, Us: Nkf.
Hladunewich MA. 2017. Chronic Kidney Disease and Pregnancy. Semin Nephrol. https://doi.org/10.1016/j.semnephrol.2017.05.005.
Hartono, A. 2013.Prinsip Diet Penyakit Ginjal. Jakarta: Arcan.
Pranandari Restu dan Woro Supadmi. 2015. Faktor Risiko Gagal Ginjal Kronik di Unit Hemodialisis Rsud Wates Kulon Progo. Majalah Farmaseutik. 2015;11(2):316-320. https://doi.org/10.22146/farmaseutik.v11i2.24120.
Tedla F.M., Brar A., Browne R. and Brown C., 2011, Hypertension in Chronic Kidney Disease: Navigating the Evidence, International Journal of Hypertension, United States of America.https://doi.org/10.4061%2F2011%2F132405.
NFK-KDOQI, 2013.Clinical Practice Guidelines On Hypertension And Antihypertensive Agents In Chronic Kidney Disease, Guideline 12. https://doi.org/10.1053/j.ajkd.2004.03.003.
Harold, J.2010. Renal Disease. Dalam Phatopysiology Of Disease, Editor Mcphee S.J, Ganong W.F. CHAPTER 16TH. NEW YORK: Mc-Graw Hill.
Subekti, I., 2014. Neuropati Diabetik. In: S. Setiati. Buku Ajar Ilmu Penyakit Dalam Jilid II Edisi VI. Jakarta: Interna Publishing, pp. 2395-9.
Wells, G. Barbara., Dipiro, Joseph. T., Schwinghammer, Terry. L., Dipiro, Cecily. V. 2015. Pharmacotheraphy Handbook Ninth Edition.New York: Mcgraw Hill.
Fransisca, Kristiana. 2011. Waspadalah 24 Penyebab Ginjal Rusak. Jakarta: Penerbit Cerdas Sehat.
Drugs.com. 2021. Drug Interactions Checker. Tersedia (https://www.drugs.com/drug_interactions.html).
Tatro, DS. 2015.Drug Interaction Fact 2015: the authority on drug interactions. By Wolters Kluwer Health, Inc.
Claire L Preston. 2011. Stockley’s Drug Interactions 11 Edition. Pharmaceutical Press. United States.
Baxter, Karen., 2012, Stockley ’ s Drug Interactions – Pocket Compani. K. Baxter, ed., London: Pharmaceutical Press. https://doi.org/10.3163%2F1536-5050.99.2.016.
Lexicomp. 2018. Wolters kluwer clinical drug information : interact. Woltres kluwer company.
Shibata K, Akagi Y, Nozawa N, Shimomura H, Aoyama T. 2017. Influence of nonsteroidal antiinflammatory drugs on aspirin’s antiplatelet effects and suggestion of the most suitable time for administration of both agents without resulting in interaction. Journal of Pharmaceutical Health Care and Sciences. https://doi.org/10.1186%2Fs40780-017-0078-7.
Philip Masson, Webster, Angela C, Evi V Nagler, Rachael L Morton. 2017. Chronic Kidney Disease. The Lancet. Elsevier Ltd, 389(10075), pp. 1238– 1252. doi: https://doi.org/10.1016/S0140-6736(16)32064-5
Anderson, E. T., & McFarlane, J. 2011. Community as Partner: Theory and Practice in Nursing (6th ed.). Philadelphia: Wolters Kluwer Health. Lippincott Williams & Wilkins.
Opie LH, Horowitz JD. 2009. B-blocking agents. In: Opie LH, Gersh BJ, editors. Drugs for the Heart (Seventh Edition). Philadelphia: Elsevier Saunders.
DOI: https://doi.org/10.37311/ijpe.v2i2.13333
Refbacks
- There are currently no refbacks.
Copyright (c) 2022 Siti Alfanda Makmur, Madania Madania, Nur Rasdianah
Indonesian Journal of Pharmaceutical Education is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.